NetForum uses cookies to ensure that we give you the best experience on our website. If you continue to use the site, we'll assume that you are happy to receive these cookies on the NetForum website. Read about our cookies.
NetForum Community
Learn. Share. Optimize.
Log in | Sign up now | Submit content | Contact
Go to similar content

mDIXON TSE and DWI of ankle melanoma using Prodiva 1.5T

Case Study
Takahashi, Mamoru, M.D. Seirei Mikatahara General Hospital • Japan

Patient history

This MRI case study of a melanoma in the ankle of a 72-year-old female was performed on Prodiva 1.5T at Seirei Mikatahara General Hospital, Japan.

MR examination

The MRI examination of this patient was performed on Prodiva 1.5T.

Images

Click on an image to enlarge
mDIXON TSE T1W water mDIXON TSE T1W in phase
mDIXON TSE T1W water
mDIXON TSE T1W in phase
mDIXON TSE T2W water mDIXON TSE T2W in phase
mDIXON TSE T2W water
mDIXON TSE T2W in phase
DWI inverted ADC
DWI inverted
ADC

Impact of using Prodiva 1.5T

According to Dr. Takahashi, Prodiva 1.5T provides high SNR and the excellent quality of fat saturation with mDIXON XD is really appreciated, especially in the neck area and joints of extremities. In this case study, mDIXON TSE provides excellent fat suppression, without the distortion that is often seen at such extremities.

 

Dr Takahashi says that the flexible dS MSK coil helps to make patient set-up simple. The coil is also comfortable for the hospital's large population of eldery patients. And the table height is relatively low, which helps patients with limited mobility to enter the scanner easily.

 

 

 

Read more in:

FieldStrength article: An excellent fit to expand the imaging center, Prodiva 1.5T

 

 

 

Results from case studies are not predictive of results in other cases. Results in other cases may vary.

 

 

 



This content has been made possible by NetForum Community.
Share this on: Share your link in twitter Share your link in facebook Share your link on LinkedIn Print Rate this article: Log in to vote

 
Rating:
Votes:
0
Views:
98
Added:
Feb 6, 2018

Rate this:
Log in to vote
 

Case Study
Prodiva 1.5T
Release 5
Ankle, DWI, mDIXON TSE, melanoma, Musculoskeletal, Oncology
 

Clinical News
Best Practices
Case Studies
Publications and Abstracts
White Papers
Web seminars and Presentations
ExamCards
Protocols
Application Tips and FAQ
Training
Try an Application
Business News
Case Studies
White Papers
Web Seminars and Presentations
Utilization Services
Contributing Professionals
Contributing Institutions
Become a Contributor